Pirfenidone: A Review of Its Use in Idiopathic Pulmonary Fibrosis

Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events

(2014) Ulrich Costabel et al.   ADVANCES IN THERAPY

Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts

(2014) Enrico Conte et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

(2014) Talmadge E. King et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

(2014) Luca Richeldi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis

(2014) Dominique Valeyre et al.   RESPIROLOGY

Normativa sobre el diagnóstico y tratamiento de la fibrosis pulmonar idiopática

(2013) Antoni Xaubet et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Klinische Erfahrungen mit Pirfenidon in der Therapie der idiopathischen Lungenfibrose

(2013) F. Bonella et al.   DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT

Real world experiences: Pirfenidone is well tolerated in patients with idiopathic pulmonary fibrosis

(2013) Nazia Chaudhuri et al.   RESPIRATORY MEDICINE

A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis

(2012) Imre Noth et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

(2011) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pirfenidone

(2011) Natalie J. Carter   DRUGS

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

(2011) Paul W Noble et al.   LANCET

Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology

(2010) C. Vancheri et al.   EUROPEAN RESPIRATORY JOURNAL

Pirfenidone in idiopathic pulmonary fibrosis

(2009) H. Taniguchi et al.   EUROPEAN RESPIRATORY JOURNAL

Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adults

(2009) C.M. Rubino et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Superoxide scavenging activity of pirfenidone–iron complex

(2008) Yoshihiro Mitani et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis

(2008) Hisashi Oku et al.   EUROPEAN JOURNAL OF PHARMACOLOGY